Cyclosporine A-induced increase in glomerular cyclic GMP in rats and the involvement of the endothelin(B) receptor

Ivan Tack, Encarna Marin-Castano, Jean Loup Bascands, Christiane Pecher, Jean Louis Ader, Jean Pierre Girolami

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

1. A transient two fold increase in the cyclic GMP content was observed in rat freshly isolated glomeruli 6 to 9 h after a single subcutaneous injection of 20 mg kg-1 cyclosporine A (CsA) in conscious animals. 2. In vitro stimulation with endothelin 3 (ET-3) of isolated glomeruli obtained from CsA-untreated rats resulted in a dose-dependent increase in cyclic GMP content. The increase observed with 10 nM ET-3 was similar to that observed in glomeruli isolated 9 h after in vivo CsA administration. 3. The rise in glomerular cyclic GMP content after in vivo CsA injection was prevented by in vivo treatment with L-NAME (10 mg kg-1) or by in vitro calcium deprivation of the incubation medium. 4. The stimulating effects of CsA on glomerular cyclic GMP content were inhibited by in vivo administration of the ET(B) receptor antagonist BQ-788 (2. mg kg-1) but not by the ET(A) receptor antagonist BQ-123 (2 mg kg-1). 5. The maximum increase in glomerular cyclic GMP content induced in vitro by acetylcholine (100 μM) and by ET-3 (100 nM) was slightly lower (approximately by 20-25%, P < 0.05) in glomeruli from CsA-treated rats than in glomeruli from untreated rats. In contrast, the maximum increase achieved with 1 μM sodium nitroprusside was similar in both groups. 6. A single subcutaneous injection of CsA did not significantly alter the glomerular mRNA expression of constitutive endothelial NO synthase (eNOS), as evaluated by RT-PCR, whereas the mRNA expression of the inducible NO synthase (iNOS), which follows pretreatment with lipopolysaccharide, was prevented. 7. These results indicate that in vivo administration of a single dose of cyclosporine A transiently increases the cyclic GMP content of freshly isolated glomeruli, and that activation of ET(B) receptors and stimulation of the NO pathway are involved in this process. Furthermore, a single administration of CsA does not impair eNOS mRNA expression and only slightly reduces NO-dependent glomerular cyclic GMP production.

Original languageEnglish
Pages (from-to)433-440
Number of pages8
JournalBritish Journal of Pharmacology
Volume121
Issue number3
DOIs
StatePublished - Jun 11 1997
Externally publishedYes

Fingerprint

Endothelin B Receptors
Cyclic GMP
Cyclosporine
Endothelin-3
Nitric Oxide Synthase
Subcutaneous Injections
Messenger RNA
NG-Nitroarginine Methyl Ester
Nitroprusside
Acetylcholine
Lipopolysaccharides
Calcium
Polymerase Chain Reaction

Keywords

  • Cyclic GMP
  • Cyclosporine A
  • Endothelins
  • Glomerulus
  • Kidney
  • Nitric oxide
  • Nitric oxide synthases

ASJC Scopus subject areas

  • Pharmacology

Cite this

Cyclosporine A-induced increase in glomerular cyclic GMP in rats and the involvement of the endothelin(B) receptor. / Tack, Ivan; Marin-Castano, Encarna; Bascands, Jean Loup; Pecher, Christiane; Ader, Jean Louis; Girolami, Jean Pierre.

In: British Journal of Pharmacology, Vol. 121, No. 3, 11.06.1997, p. 433-440.

Research output: Contribution to journalArticle

Tack, Ivan ; Marin-Castano, Encarna ; Bascands, Jean Loup ; Pecher, Christiane ; Ader, Jean Louis ; Girolami, Jean Pierre. / Cyclosporine A-induced increase in glomerular cyclic GMP in rats and the involvement of the endothelin(B) receptor. In: British Journal of Pharmacology. 1997 ; Vol. 121, No. 3. pp. 433-440.
@article{dbf33b0038774a0283fcd88312b97af1,
title = "Cyclosporine A-induced increase in glomerular cyclic GMP in rats and the involvement of the endothelin(B) receptor",
abstract = "1. A transient two fold increase in the cyclic GMP content was observed in rat freshly isolated glomeruli 6 to 9 h after a single subcutaneous injection of 20 mg kg-1 cyclosporine A (CsA) in conscious animals. 2. In vitro stimulation with endothelin 3 (ET-3) of isolated glomeruli obtained from CsA-untreated rats resulted in a dose-dependent increase in cyclic GMP content. The increase observed with 10 nM ET-3 was similar to that observed in glomeruli isolated 9 h after in vivo CsA administration. 3. The rise in glomerular cyclic GMP content after in vivo CsA injection was prevented by in vivo treatment with L-NAME (10 mg kg-1) or by in vitro calcium deprivation of the incubation medium. 4. The stimulating effects of CsA on glomerular cyclic GMP content were inhibited by in vivo administration of the ET(B) receptor antagonist BQ-788 (2. mg kg-1) but not by the ET(A) receptor antagonist BQ-123 (2 mg kg-1). 5. The maximum increase in glomerular cyclic GMP content induced in vitro by acetylcholine (100 μM) and by ET-3 (100 nM) was slightly lower (approximately by 20-25{\%}, P < 0.05) in glomeruli from CsA-treated rats than in glomeruli from untreated rats. In contrast, the maximum increase achieved with 1 μM sodium nitroprusside was similar in both groups. 6. A single subcutaneous injection of CsA did not significantly alter the glomerular mRNA expression of constitutive endothelial NO synthase (eNOS), as evaluated by RT-PCR, whereas the mRNA expression of the inducible NO synthase (iNOS), which follows pretreatment with lipopolysaccharide, was prevented. 7. These results indicate that in vivo administration of a single dose of cyclosporine A transiently increases the cyclic GMP content of freshly isolated glomeruli, and that activation of ET(B) receptors and stimulation of the NO pathway are involved in this process. Furthermore, a single administration of CsA does not impair eNOS mRNA expression and only slightly reduces NO-dependent glomerular cyclic GMP production.",
keywords = "Cyclic GMP, Cyclosporine A, Endothelins, Glomerulus, Kidney, Nitric oxide, Nitric oxide synthases",
author = "Ivan Tack and Encarna Marin-Castano and Bascands, {Jean Loup} and Christiane Pecher and Ader, {Jean Louis} and Girolami, {Jean Pierre}",
year = "1997",
month = "6",
day = "11",
doi = "10.1038/sj.bjp.0701153",
language = "English",
volume = "121",
pages = "433--440",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Cyclosporine A-induced increase in glomerular cyclic GMP in rats and the involvement of the endothelin(B) receptor

AU - Tack, Ivan

AU - Marin-Castano, Encarna

AU - Bascands, Jean Loup

AU - Pecher, Christiane

AU - Ader, Jean Louis

AU - Girolami, Jean Pierre

PY - 1997/6/11

Y1 - 1997/6/11

N2 - 1. A transient two fold increase in the cyclic GMP content was observed in rat freshly isolated glomeruli 6 to 9 h after a single subcutaneous injection of 20 mg kg-1 cyclosporine A (CsA) in conscious animals. 2. In vitro stimulation with endothelin 3 (ET-3) of isolated glomeruli obtained from CsA-untreated rats resulted in a dose-dependent increase in cyclic GMP content. The increase observed with 10 nM ET-3 was similar to that observed in glomeruli isolated 9 h after in vivo CsA administration. 3. The rise in glomerular cyclic GMP content after in vivo CsA injection was prevented by in vivo treatment with L-NAME (10 mg kg-1) or by in vitro calcium deprivation of the incubation medium. 4. The stimulating effects of CsA on glomerular cyclic GMP content were inhibited by in vivo administration of the ET(B) receptor antagonist BQ-788 (2. mg kg-1) but not by the ET(A) receptor antagonist BQ-123 (2 mg kg-1). 5. The maximum increase in glomerular cyclic GMP content induced in vitro by acetylcholine (100 μM) and by ET-3 (100 nM) was slightly lower (approximately by 20-25%, P < 0.05) in glomeruli from CsA-treated rats than in glomeruli from untreated rats. In contrast, the maximum increase achieved with 1 μM sodium nitroprusside was similar in both groups. 6. A single subcutaneous injection of CsA did not significantly alter the glomerular mRNA expression of constitutive endothelial NO synthase (eNOS), as evaluated by RT-PCR, whereas the mRNA expression of the inducible NO synthase (iNOS), which follows pretreatment with lipopolysaccharide, was prevented. 7. These results indicate that in vivo administration of a single dose of cyclosporine A transiently increases the cyclic GMP content of freshly isolated glomeruli, and that activation of ET(B) receptors and stimulation of the NO pathway are involved in this process. Furthermore, a single administration of CsA does not impair eNOS mRNA expression and only slightly reduces NO-dependent glomerular cyclic GMP production.

AB - 1. A transient two fold increase in the cyclic GMP content was observed in rat freshly isolated glomeruli 6 to 9 h after a single subcutaneous injection of 20 mg kg-1 cyclosporine A (CsA) in conscious animals. 2. In vitro stimulation with endothelin 3 (ET-3) of isolated glomeruli obtained from CsA-untreated rats resulted in a dose-dependent increase in cyclic GMP content. The increase observed with 10 nM ET-3 was similar to that observed in glomeruli isolated 9 h after in vivo CsA administration. 3. The rise in glomerular cyclic GMP content after in vivo CsA injection was prevented by in vivo treatment with L-NAME (10 mg kg-1) or by in vitro calcium deprivation of the incubation medium. 4. The stimulating effects of CsA on glomerular cyclic GMP content were inhibited by in vivo administration of the ET(B) receptor antagonist BQ-788 (2. mg kg-1) but not by the ET(A) receptor antagonist BQ-123 (2 mg kg-1). 5. The maximum increase in glomerular cyclic GMP content induced in vitro by acetylcholine (100 μM) and by ET-3 (100 nM) was slightly lower (approximately by 20-25%, P < 0.05) in glomeruli from CsA-treated rats than in glomeruli from untreated rats. In contrast, the maximum increase achieved with 1 μM sodium nitroprusside was similar in both groups. 6. A single subcutaneous injection of CsA did not significantly alter the glomerular mRNA expression of constitutive endothelial NO synthase (eNOS), as evaluated by RT-PCR, whereas the mRNA expression of the inducible NO synthase (iNOS), which follows pretreatment with lipopolysaccharide, was prevented. 7. These results indicate that in vivo administration of a single dose of cyclosporine A transiently increases the cyclic GMP content of freshly isolated glomeruli, and that activation of ET(B) receptors and stimulation of the NO pathway are involved in this process. Furthermore, a single administration of CsA does not impair eNOS mRNA expression and only slightly reduces NO-dependent glomerular cyclic GMP production.

KW - Cyclic GMP

KW - Cyclosporine A

KW - Endothelins

KW - Glomerulus

KW - Kidney

KW - Nitric oxide

KW - Nitric oxide synthases

UR - http://www.scopus.com/inward/record.url?scp=0030974767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030974767&partnerID=8YFLogxK

U2 - 10.1038/sj.bjp.0701153

DO - 10.1038/sj.bjp.0701153

M3 - Article

C2 - 9179384

AN - SCOPUS:0030974767

VL - 121

SP - 433

EP - 440

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 3

ER -